|
XTL BIopharmaceuticals Limited - Company Profile Snapshot
| Company Profile: |
XTL BIopharmaceuticals Limited |
| Ticker: |
XTLB |
| Exchanges: |
OTH |
| 2008 Sales: |
21,167,000 |
| Major Industry: |
Drugs, Cosmetics & Health Care |
| Sub Industry: |
Ethical Drug Manufacturers |
| Country: |
ISRAEL |
| Employees: |
8 |
Business Description
XTL BIopharmaceuticals Limited. The Group's principal activity is the acquisition, development and commercialization of therapeutics for the treatment of neurophatic pain and, Hepatitis C. The Company is a development stage biotechnology company. It does not yet have any product sales and expects to consume cash until products are commercialised. The Company's shares are traded on the London, New York and Tel Aviv Stock Exchange.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
